SEC Form 4 · accession 0001613377-17-000003
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Strayer
Officer — Chief Science/Medical Officer
Period of report
Feb 16, 2017
Accepted (ET)
Feb 21, 2017 · 2:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2017 | P | 9,892 | $0.46 | A | 33,867 | D |
Table II — derivative securities
No Table II lines on this filing.